(Q68134847)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Intensive retreatment of adults and children with acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

main subject

lymphoblastic leukemia

1 reference

D'Emilio A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

R. Bassan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

P. E. Cornelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

R. Battista

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

F. Terzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

M. Buelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

A. Rambaldi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

P. Viero

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

A. D'Emilio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

E. Dini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

T. Barbui

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1592360

12 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1592360

12 October 2022

publication date

1 March 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

105-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

Combination chemotherapy for haematological relapse in adult acute lymphoblastic leukaemia (ALL)

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Treatment of acute lymphoblastic leukemia in adults

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Treatment of the lymphoid blast crisis of chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100206

7 January 2021

Identifiers

DOI

10.1002/HON.2900100206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1592360%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference